Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
NewsHumanitarian Action with technical support from ITPCru has opposed Gilead’s patent in Russia for the combination of two antiretroviral drugs,...
Read more about Russian NGOs oppose Gilead’s patent for HIV drug, Truvada
-
Danylo: Positive attitudes start with teaching – and effective HIV treatment
InterviewDanylo (name changed), 18, shares information about HIV with his university friends in Cherkassy, Ukraine. For example, “that HIV is...
Read more about Danylo: Positive attitudes start with teaching – and effective HIV treatment
-
Letter to ViiV Healthcare: No more time to waste – increase access to dolutegravir in Eastern Europe and Central Asia
News Press releaseDolutegravir is an essential drug in HIV treatment, recommended by the World Health Organization (WHO). Despite the drug being approved...
-
Vera: HIV targets won’t be met without gender equality and accessible treatment
InterviewOn the day that new research is published, showing that countries are being overcharged by $34 billion a year for HIV drugs, Vera Varyga,...
Read more about Vera: HIV targets won’t be met without gender equality and accessible treatment
-
New data: Treat HIV for just four weeks of global pharmaceutical sales
News Press releaseThe Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at...
Read more about New data: Treat HIV for just four weeks of global pharmaceutical sales
-
AIDS 2020 leadership workshop: Strategies for lowering drug prices
NewsActivists, policy-makers, researchers and healthcare providers joined a leadership workshop led by ITPC’s Make Medicines Affordable campaign at AIDS 2020...
Read more about AIDS 2020 leadership workshop: Strategies for lowering drug prices
-
COVID-19: Another of Gilead’s FIVE patent applications on remdesivir is opposed in Argentina
NewsOur campaign partner, Fundación GEP, has filed a second patent opposition against one of Gilead’s numerous patent applications for the...
-
AIDS 2020 exhibition: Love, life and riots
News Photo galleryWe’re exhibiting at #AIDS2020Virtual, the world’s largest virtual AIDS conference. Our photo exhibition Love, Life and Riots will be on...
-
What’s on: AIDS 2020 Virtual for treatment activists
NewsKicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
Read more about What’s on: AIDS 2020 Virtual for treatment activists
-
Ukraine: 100% LIFE opposes patent on TB drug for children
NewsOur campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
Read more about Ukraine: 100% LIFE opposes patent on TB drug for children
